• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
2011 O.U.S. Markets For External Radiation Therapy Product Image

2011 O.U.S. Markets For External Radiation Therapy

  • Published: May 2011
  • Region: United States
  • 84 Pages
  • Life Science Intelligence

2011 O.U.S. Markets For External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for:

- High quality, granular, deeply segmented data
- Access to senior analysts to conduct proprietary modeling and custom market simulations
- Access to useable source data for in-house customization and adoption of market models

The deliverables include:

- Initial report with most recent data available (PDF and Excel)
- Extensive access to senior analyst for proprietary add-on analysis
- Online platform making the data useable and interactive

1. ESTABLISHED AND EMERGING TECHNOLOGIES

1.1 Features of Established Technologies
1.2 Challenges for Established Technologies

1.2.1 Conformality

1.2.2 Anoxic Tissues

1.2.2.1 Economic Factors

1.2.2.1.1 Reimbursement and National Policies and Initiatives

1.2.2.1.2 System Prices & Associated Costs

1.2.2.1.3 The Global Economy

Exhibit 1-1: External Radiation Therapy by Type
Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy Systems
Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for External Radiation Therapy and SRS
Exhibit 1-4: Features of Particle Therapy Centers
Exhibit 1-5: Challenges Associated with Available Technologies
Exhibit 1-6: Established and Emerging Technologies

2. OUS MARKETS FOR EXTERNAL RADIATION THERAPY

Exhibit 2-1: External Radiation Therapy, OUS Market Forecast, 2007-2013
Exhibit 2-2: OUS External Radiation Therapy, Supplier Shares, 2008
Exhibit 2-3: Factors Influencing the OUS Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
Exhibit 2-4: External Radiation Therapy in Europe, Linear Accelerator & Gamma-Ray Systems, 2007-2013
Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, European Shares in 2008
Exhibit 2-6: European Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems in Europe, 2008 & 2013
Exhibit 2-8: AP & ROW External Radiation Therapy, Linear Accelerator & Gamma-Ray Systems, 2007-2013
Exhibit 2-9: Linear Accelerator & Gamma-Ray Systems, AP & ROW Shares, 2008
Exhibit 2-10: AP & ROW Market Forecast by Type of System, Gamma-Ray & Linear Accelerator Systems, 2007-2013
Exhibit 2-11: Gamma-Ray & Linear Accelerator Systems in AP&ROW, 2008 & 2013
Exhibit 2-12: Factors Influencing the OUS Market for External Radiation Therapy and SRS from 2007-2013
Exhibit 2-13: External Radiation Therapy, European Market Forecast by Application, 2007-2013
Exhibit 2-14: SRS and External Radiation Systems in Europe, 2008 & 2013
Exhibit 2-15: Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
Exhibit 2-16: Stereotactic Radiosurgery - European Patient Volumes by Type, 2007-2013
Exhibit 2-17: Stereotactic Radiosurgery - Utilization by Patient Type in Europe, 2007-2013
Exhibit 2-18: Extracranial Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
Exhibit 2-19: Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
Exhibit 2-20: Stereotactic Radiosurgery - European Procedures by Type, 2007-2013
Exhibit 2-21: Stereotactic Radiosurgery in Europe - Utilization by Procedure, 2007-2013
Exhibit 2-22: Extracranial Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
Exhibit 2-23: Breast, Lung and Prostate Patients Treated with Radiation Therapy in Europe, 2007-2013
Exhibit 2-24: Other Patients Treated with External Radiation Therapy in Europe, 2007-2013
Exhibit 2-25: External Radiation Therapy in Europe, Breast, Lung, and Prostate Procedures, 2007-2013
Exhibit 2-26: Other External Radiation Therapy Procedures in Europe, 2007-2013
Exhibit 2-27: External Radiation Therapy, AP & ROW Market Forecast by Application, 2007-2013
Exhibit 2-28: Stereotactic Radiosurgery - AP & ROW Patient Volumes, 2007-2013
Exhibit 2-29: Stereotactic Radiosurgery - AP & ROW Patient Volumes by Type, 2007-2013
Exhibit 2-30: Stereotactic Radiosurgery - AP & ROW Utilization by Type of Patients, 2007-2013
Exhibit 2-31: Stereotactic Radiosurgery - AP & ROW Procedure Volumes, 2007-2013
Exhibit 2-32: Stereotactic Radiosurgery - AP & ROW Procedures by Type, 2007-2013
Exhibit 2-33: Breast, Lung and Prostate Patients Treated with Radiation Therapy in AP & ROW Countries, 2007-2013
Exhibit 2-34: Other Patients Treated with External Radiation Therapy in AP & ROW Countries, 2007-2013
Exhibit 2-35: External Radiation Therapy in AP & ROW Countries, Breast, Lung, and Prostate Procedures, 2007-2013
Exhibit 2-36: Other External Radiation Therapy Procedures in AP & ROW Countries, 2007-2013
Exhibit 2-37: Factors Influencing the OUS Market for Particle Therapy, 2007-2013
Exhibit 2-38: Particle Therapy, European Market Forecast, 2007-2013
Exhibit 2-39: Particle Therapy in Europe by Type, 2007-2013
Exhibit 2-40: Particle Therapy Systems, European Supplier Shares in 2008
Exhibit 2-41: Particle Therapy, European Patient Volumes, 2007-2013
Exhibit 2-42: Particle Therapy, AP & ROW Market Forecast, 2007-2013
Exhibit 2-43: Particle Therapy in Europe by Type, 2007-2013
Exhibit 2-44: Particle Therapy Systems, AP & ROW Supplier Shares in 2008
Exhibit 2-45: Particle Therapy, AP & ROW Patient Volumes, 2007-2013

3. MERGERS, ACQUISITIONS, AND PARTNERSHIPS

4. EMERGING COMPANIES

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos